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response of patients undergoing the same type of surgery. The aim of the work is to evaluate the
effects of two anesthetic techniques: total intravenous anesthesia (TIVA) with propofol versus vol-
atile induction and maintenance anesthesia (VIMA) with sevoﬂurane, on cellular immune functions
in patients undergoing meniscectomy.
Patients and methods: 50 Adult patients scheduled for meniscectomy were randomly assigned into
two groups: TIVA group (Group T: n= 25), and VIMA group (Group V: n= 25). A blood sample
was collected 24 h before surgery (Sbasal). The ﬁrst sample on the day of operation was collected
just before the induction of anesthesia (S1), then 3 h later after induction (S2), and lastly 24 h after
surgery (S3). CRP levels were assayed and T-lymphocyte subpopulations were investigated by ﬂow-
cytometry.
Results: CRP was increased at (S1) and reached its maximum levels at (S3) in both groups. CRP
levels at (S3) were signiﬁcantly higher in TIVA compared to VIMA groups. A signiﬁcant decrease in
the percentage of CD3, CD4 and decreased CD4/CD8 ratio occurred at (S2) and (S3) in both
groups but more signiﬁcantly with TIVA. CD8 showed no signiﬁcant changes in both groups.
NK cells decreased signiﬁcantly at (S2) and (S3) in both groups, with no signiﬁcant differences
between the two groups. The percentage of HLA-DR showed no signiﬁcant changes all through
the study time in both groups.329364.
(S.H. Waly).
Anesthesiologists. Production
an Society of Anesthesiologists.
lsevier
 under CC BY-NC-ND license.
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General anesthesia and surgical stress have a major role in
affecting patients’ cellular immunity [1]. Different anesthetic
techniques may have different effects on the immune response
of patients undergoing the same type of surgery [2]. Since both
anesthesia and surgery affect the immune system in many
ways, a large number of studies have been paying concern to
the perioperative immune responses [1]. Moreover, the effect
of anesthetics per se on the immune system has taken a lot
of attention [3].
A large number of in vitro cellular immunity studies were
performed upon T-lymphocytes to explore the effect of inhala-
tional anesthetics upon them, and they revealed inhibition of
T-lymphocytes functions [4,5]. In vivo investigations of T-lym-
phocyte functions revealed that the effect of both anesthesia
and surgery lead to combined suppression of the proliferative
response as well as the number of circulating T-lymphocytes
[6]. However, other studies have shown no alteration of T lym-
phocytic functions in individuals working in the ﬁeld of anes-
thesia [4,7].
Propofol is a commonly used intravenous anesthetic which
is characterized by its short duration of action and has been
effectively used for induction and maintenance of anesthesia
[8].
Sevoﬂurane is a general inhalational anesthetic that can be
used for inhalational induction and maintenance of general
anesthesia due to its non-irritant and pleasant odor [9]. Sevo-
ﬂurane depressed the release of inﬂammatory mediators and
reduced neutrophil accumulation in an in vitro study incorpo-
rating a model of endotoxin-induced injury in alveolar epithe-
lial cells [10]. In an animal study, the impact of sevoﬂurane
anesthesia on the immune system was evaluated without sur-
gery. In that study, sevoﬂurane decreased the number of
peripheral blood lymphocytes and stimulated T-helper (CD4)
lymphocytes [11].
The aim of the present study is to evaluate the effects of two
anesthetic techniques: total intravenous anesthesia (TIVA)
with propofol versus volatile induction and maintenance anes-
thesia (VIMA) with sevoﬂurane, on cellular immune functions
in patients undergoing meniscectomy.2. Patients and methods
After the approval of our local ethics committee, 50 adult pa-
tients (American Society of Anaesthesiologists class I and class
II) scheduled for meniscectomy with a written informed con-
sent were enrolled in the present study. Exclusion criteria were
preexisting chest diseases (determined by clinical examination,
chest X-ray), insulin-dependent diabetes mellitus, and renal,
hepatic, or cerebrovascular diseases. Patients with preoperative
signs of infection (such as white blood cells (WBCs) count
>12,000/lL, body temperature >38 C, and C-reactive pro-
tein [CRP] >5 mg/dL), immune system related disorders,
endocrine pathologies, allergic reactions, pregnancy or contra-ceptive bills, and steroids or other immunologic therapies were
also excluded.
Patients were randomly assigned into two groups: TIVA
group (Group T), VIMA group (Group V). Patients were gi-
ven consecutive numbers and those with odd numbers received
TIVA while those with even numbers received VIMA.
All patients were premedicated with 0.1 mg/kg midazolam
and 0.5 mg atropine intramuscularly 1 h before surgery. All
patients were also given a loading dose of fentanyl 1 lg/kg
i.v. and 100% oxygen via a face mask for 2–3 min before
induction. Supplementary doses of fentanyl were administered
intraoperatively as required.
In Group T, induction was performed using propofol 1–
2.5 mg/kg and anesthesia was maintained with propofol 4–
8 mg/kg/h. In Group V, induction was done using a face mask
with sevoﬂurane starting at 8% with an initial fresh gas ﬂow
(FGF) of 6 L/min for 1–3 min and reaching down to a FGF
of 3 L/min during maintenance together with 1.5–3.5% sevo-
ﬂurane. For all patients, rocuronium (Esmeron) 0.7 mg/kg
i.v. was administered to facilitate tracheal intubation. Muscle
relaxation was maintained using incremental doses of rocuro-
nium (0.07 mg/kg) as required. Patients were ventilated to
maintain an end-tidal PCo2 of 35–45 mm Hg throughout the
whole procedure. Depth of anesthesia was monitored by clin-
ical signs and hemodynamic responses to surgical stimuli.
When adequate depth was achieved, maintenance dose of
either propofol or sevoﬂurane was kept constant. ECG, pulse
oximetry, capnography and non-invasive blood pressure mon-
itoring were also applied to all patients.
After skin closure, abrupt discontinuation of either sevoﬂu-
rane or propofol and reversal of residual muscle relaxation
were done and the lungs were ventilated with 100% oxygen
at a ﬂow rate of at least 6 L/min.
2.1. Blood samples collection
For all patients four venous blood samples were collected in
two tubes with ethylendiamine tetra-acetic acid (EDTA) one
for fresh ﬂow-cytometry analysis and the other for CRP anal-
ysis. A sample was collected 24 h before surgery (Sbasal) to
achieve the basal ﬁndings of the patient. The ﬁrst sample on
the day of operation was collected just before the induction
of anesthesia (S1), the second sample was collected 3 h after
induction (S2) and the third sample was collected 24 h after
surgery (S3).
2.2. CRP detection
After being centrifuged, plasma was stored at 20 C until as-
sayed. CRP levels were assayed by immunoturbidimetric meth-
od with Roche kits, using modular analytics P module (Roche
Diagnostics, Manheim, Germany). The sensitivity, dynamic
range, and accuracy of this test were the following: 0.425%,
1–280%, and 4.61% for CRP. The total protein concentrations
of blood samples were measured and the level CRP was cor-
rected using the changes in the total protein concentrations,
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sults postoperatively.
2.3. Flow cytometric analysis
The immune system represented by T-lymphocytes and its sub-
population and monocytes were investigated by FACSCalibur
ﬂow-cytometer (Becton Dickinson Biosciences, San Jose,
USA). A selected panel (CD3, CD4, CD8, CD56, CD14 and
HLA-DR) had been analyzed in all cases. The antibodies’
combination for ﬂow cytometry was labeled with FITC and
PE. All monoclonal antibodies used were purchased from Bec-
ton Dickinson. Cells were stained by whole blood protocolTable 1 Patients’ general data.
Group T (n= 25) Group V (n= 25)
Age (years) 30 ± 8 31 ± 8
Sex (male/female) 22/3 21/4
Weight (kg) 78 ± 13 76 ± 17
Length of surgery (min) 35 ± 9 33 ± 12
Length of anesthesia (min) 47 ± 8 45 ± 11
Data were expressed as mean ± SD. P> 0.05 considered
signiﬁcant.
Table 2 Comparison between the levels of CRP (mg/dl) in the two
24 h Before surgery (Sbasal) Just before
of anesthes
Group T (n= 25) 1.63 [0.95–3.67] 5.87 [2.20–1
Group V (n= 25) 1.64 [0.51–4.06] 4.95 [3.95–2
Data were expressed as median and range. P> 0.05 considered signiﬁca
a Signiﬁcantly higher as compared to basal CRP levels in the same gro
b Signiﬁcantly higher as compared to CRP 3 h after the induction of an
c Signiﬁcantly higher as compared to same time CRP in the other grou
Table 3 Comparisons between the percentages of lymphocytes sub
24 h Before
surgery (Sbasal)
Just befor
of anesthe
CD 3 Group T 76.9 ± 3.7 71.2 ± 6.3
Group V 77.5 ± 2.6 70.3 ± 3.3
CD 4 Group T 48.01 ± 6.3 48.6 ± 4.2
Group V 47.06 ± 6.1 47.1 ± 5.8
CD 8 Group T 22.86 ± 5.0 21.1 ± 2.8
Group V 21.39 ± 5.3 20.7 ± 6.0
CD4/CD8 ratio Group T 2.1 ± 0.2 2.3 ± 0.2
Group V 2.2 ± 0.2 2.3 ± 0.3
CD56 (NK cells) Group T 20.8 ± 6.2 20.3 ± 4.8
Group V 21.3 ± 4.9 20.9 ± 5.2
Data were expressed as mean ± SD; P> 0.05 considered as signiﬁcant.
a Signiﬁcantly lower as compared to basal data within the same group.
b Signiﬁcantly lower as compared to data obtained just after the induc
c Signiﬁcantly lower as compared to same time data of the other group[12]. Peripheral blood 50 lL aliquots were immuno-stained
with Moab (20 min at 4 C), then incubated for 10 min in
2 mL of diluted (1:10) lysing solution, washed three times in
phosphate-buffered saline (PBS) containing 1% BSA, incu-
bated in 10% human AB serum, and stained cells re-suspended
in 0.5 mL PBS. Isotype controls were run with each sample to
distinguish the positive cells from the negative cells.
A total of 10,000 events were acquired for analysis using a
FACSCalibur ﬂow-cytometer equipped with CellQuest (BD
Biosciences). A First gate (G1) on the lymphoid population
according to typical light scatter characteristics was done to
determine the positivity of CD3 (T-lymphocytes), CD4 (T-
helper), CD8 (T-suppressor) and CD56 (NK cells). A second
gate (G2) was done on monocyte population with higher light
scatter characteristics than the lymphoid population to deter-
mine the expression of monocytoid HLA-DR. A marker was
considered ‘‘+’’ if expressed by at least 20% of the analyzed
cells in the lymphocytes gate.
2.4. Statistical analysis
According to a pilot study (10 patients in each group), we cal-
culated that 25 patients per group were sufﬁcient to give
P< 0.5 signiﬁcance with a conﬁdence interval 95% with a
power of 80%.
Statistical analysis was performed using the SPSS software
(SPSS, Chicago, IL, USA). All values were given asgroups in the different samples.
induction
ia (S1)
3 h After induction
of anesthesia (S2)
24 h After surgery (S3)
6.14]a 6.65 [1.76–22.66]a 12.48 [6.84–26.66]a,b,c
6.87]a 6.15 [2.59–18.44]a 9.78 [6.36–26.17]a,b
nt.
up.
esthesia in the same group.
p.
populations in the two groups in different samples.
e induction
sia (S1)
3 h After induction
of anesthesia (S2)
24 h After surgery (S3)
53.6 ± 4.2a,b,c 51.0 ± 2.0a,b,c
61.4 ± 5.9a,b 59.6 ± 5.1a,b
35.0 ± 6.1a,b,c 36.2 ± 5.3a,b,c
40.9 ± 6.2a,b 40.7 ± 6.2a,b
21.6 ± 5.1 22.1 ± 4.8
21.2 ± 4.8 20.9 ± 5.8
1.6 ± 0.2a,b,c 1.6 ± 0.2a,b,c
1.9 ± 0.3a,b 1.9 ± 0.2a,b
17.2 ± 1.8a,b 17.1 ± 1.3a,b
17.0 ± 2.6a,b 16.9 ± 5.2a,b
tion of anesthesia within the same group.
.
Table 4 Comparisons between the percentages of monocytoid HLA-DR in the two groups in different samples.
24 h Before surgery (Sbasal) Just before induction
of anesthesia (S1)
3 h After induction of anesthesia (S2) 24 h After surgery (S3)
HLA-DR Group T 33.74 ± 7.47 39.13 ± 12.93 38.71 ± 14.94 42.32 ± 6.62
Group V 31.17 ± 5.17 42.09 ± 11.62 44.07 ± 9.95 44.11 ± 7.89
Data were expressed as mean ± SD; P> 0.05 considered signiﬁcant.
Figure 1 Dot plots of ﬂowcytometric analysis show the expression of CD3, CD4 and CD8 for 2 patients 24 h after surgery. (A): for a
patient on TIVA and (B): for a patient on VIMA.
244 S.H. Waly et al.mean ± standard deviation (SD) or as median [range]. Paired
and non-paired t-tests, Mann Whitney U, and Wilcoxon tests
were applied. Differences were considered signiﬁcant at
(P< 0.05).
3. Results
There were no signiﬁcant differences regarding the general
data of the patients included in the present study (Table 1).
There were no signiﬁcant differences regarding patients’ ages,
body weights and anesthesia time between the two groups.
CRP levels were increased just before the induction of anes-
thesia (S1) in both groups and remained signiﬁcantly higher
than base line levels (Sbasal) all through the study time. The lev-
els obtained 24 h after surgery (S3) were signiﬁcantly higher
than those obtained 3 h after induction of anesthesia (S2) in
both groups. CRP levels in propofol group were increased
24 h after the induction of anesthesia more signiﬁcantly than
in the sevoﬂurane group at the same time (Table 2).
Flow-cytometric analysis detecting T-lymphocytic subpop-
ulations in the present study showed signiﬁcant decrease in
the percentage (mean ± SD) of CD3 and CD4 T lymphocytes
as well as decreased CD4/CD8 ratio 3 h after induction of
anesthesia and these changes remained 24 h after the inductionof anesthesia. The decreases in CD3, CD4, and CD4/CD8 ra-
tio in propofol group were more signiﬁcant than those in the
sevoﬂurane group. The percentage of CD8 T lymphocytes
showed no signiﬁcant changes in both groups. NK cells
(CD56) percentage showed a signiﬁcant decrease 3 h after
the induction of anesthesia and remained signiﬁcantly de-
creased 24 h later in both groups, with no signiﬁcant differ-
ences between the two groups (Table 3).
The percentage of Human leukocyte antigen (HLA-DR) on
monocytes showed no signiﬁcant changes all through the study
time, and there were no signiﬁcant differences between the two
groups (Table 4).
Fig. 1 shows ﬂowcytometric analysis plotting the expression
of CD3, CD4 and CD8 for 2 patients 24 h after surgery.
Patient (A) was on TIVA and patient (B) was on VIMA.
4. Discussion
The present study compared the immuno-modulatory effects
of two different anesthetic techniques: total intravenous anes-
thesia (TIVA) with propofol versus volatile induction and
maintenance anesthesia (VIMA) with sevoﬂurane in patients
undergoing meniscectomy and revealed that VIMA with sevo-
ﬂurane produced less immuno-suppressive effects than TIVA
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immune-suppression, as shown by increased C-reactive protein
(CRP) and disturbances in T-lymphocytes subpopulation of
the peripheral blood, in the form of decreased CD3, T-helper
lymphocytes (CD4), and natural killer cells (NK) percentages
as well as decreased T-helper/T-suppressor lymphocytes
(CD4/CD8) ratio during the postoperative period. However,
this immune-suppression was more prominent with propofol
compared to sevoﬂurane.
There may be too many factors that might lead to the
impairment of postoperative immunity when anesthesia and
surgery are combined; including systemic illness, pathology in-
volved, length of surgery, anesthetics and anesthetic techniques
[2]. Some might suggest that performing similar immuno-mod-
ulatory research in patients performing major surgeries would
reﬂect different results. However, one of the targets of the
current study was to limit the effect of surgery, thus, meniscec-
tomy was chosen (being a simple procedure with small inci-
sions with minimal stress and pain).
Alterations in acute phase reactants (APR) might occur in
response to systemic inﬂammation which occurs in association
with many conditions such as infection or trauma. Normal val-
ues of C-reactive protein (CRP) may be 0–1.0 mg/dL [13]. The
effect of anesthesia on acute phase reactants was evaluated in
many studies with controversial results [14,15]. Elisena and
coworkers [10] compared the effect of anesthesia with sevoﬂu-
rane to propofol in one lung ventilation (OLV), their study
showed signiﬁcant increase in CRP levels with propofol com-
pared to attenuate and non signiﬁcant increase in CRP with
sevoﬂurane. They even suggested a possible anti-inﬂammatory
effect of sevoﬂurane. In the current study, CRP was elevated in
both groups, yet it was more signiﬁcantly elevated with propo-
fol compared to sevoﬂurane.
Macrophages engulf antigens. Every antigen shows itself on
the surface of the macrophages. T-lymphocytes respond to
that by expressing antibodies on their membranes. These anti-
bodies are named ‘‘clusters’’. CD stands for ‘‘clusters of differ-
entiation’’, meaning that the lymphocytic subpopulation can
be differentiated from each other through the antibodies ex-
pressed on their membranes [13].
CD3 is a protein found on the surface of T-cells. This pro-
tein is necessary for the activation of an immune response of T-
cells [16]. An in vitro study compared the effects of sevoﬂurane,
isoﬂurane, and desﬂurane on human CD3 T-lymphocytes from
healthy volunteers. In that study, sevoﬂurane induced both
time and concentration dependent suppression of CD3T-lym-
phocytes. They thought that sevoﬂurane possess an anti-
inﬂammatory effect that might be attributed to an intracellular
molecular mechanism which was only detected with sevoﬂu-
rane but not with isoﬂurane or desﬂurane [17]. In the present
study, CD3 decreased in both groups; however, it was more
signiﬁcantly decreased with propofol compared to sevoﬂurane.
T-lymphocytes have two major types, one presenting the
CD4 antigen on its surface (T-helper) and the other presenting
the CD8 antigen (T-suppressor) [18]. The ratio of CD4/CD8 is
a valuable measure to assess the disturbances affecting the im-
mune system. Ratios of CD4/CD8 1.5–2.5 are considered nor-
mal [19]. Most of the researches concerned with studying the
levels of T-lymphocytes in minor surgeries showed negligible
alterations in CD4/CD8 ratio [20]. However; suppressor lym-
phocyte activity, which attenuates host defensive mechanisms
was found to be increased with sevoﬂurane with resultant low-ering of CD4/CD8 ratio [21]. In their study, Durlu and
coworkers [21] stated that although CD4/CD8 ratio was de-
creased with sevoﬂurane and increased with isoﬂurane during
the postoperative period, these changes were statistically insig-
niﬁcant. In the present study, depression of CD4/CD8 ratio
occurred during the postoperative period in both groups, with
more signiﬁcant suppression accompanied with propofol com-
pared to sevoﬂurane.
A study by Mustafa and his colleagues [22] thought that the
immune-suppression produced by TIVA with propofol is re-
lated to the high lipid content of propofol preparations and
may be attributed to its release of cytokines. However, this
study differs from the current study in that we compared total
intravenous general anesthesia with propofol versus total inha-
lation general anesthesia with sevoﬂurane, while that study
compared two intravenous agents (propofol vs thiopental).
However, another study [23] was not in agreement with the
results obtained in the current study. In that study compared
the immunological effects of sevoﬂurane were compared to
that of propofol in patients undergoing laparoscopic cholecy-
tectomy. They found that propofol group was accompanied
by a higher ratio of CD4/CD8 and lower cortisol levels indicat-
ing that propofol might even exert an immunoprotective effect.
This study might be criticized for small sample size (14 patients
in each group) which might not be enough to support such
conclusions.
One of the T-lymphocytic subpopulations is the natural
killer (NK) cells which improve bacterial clearance by priming
macrophages to assist clearing the next microbial challenges
[24], besides its cytotoxic effect against malignant cells, micro-
bial infections and some primitive normal cells [25]. NK cell
activity is thought to be suppressed by anesthetics [26]. How-
ever; some in vivo and in vitro studies revealed that the effect
of anesthesia alone on the NK cells is limited and reversible
[27,28]. In the current study, NK cells decreased during the
postoperative period for both TIVA and VIMA techniques.
However, more signiﬁcant decrease in NK cells occurred with
total intravenous general anesthesia with propofol versus total
inhalational general anesthesia with sevoﬂurane.
The mission of the human immune system is to defend the
body against exterior invasion. In order to perform this func-
tion properly, the immune system must be able to distinguish
between the subject’s own cells and other invading organisms.
This function can be done through the molecules of the major
histo-compatibility complex (MHC) [2]. One of these mole-
cules is the human leukocyte antigen (HLA). HLA molecules,
and the genes encoding them, can be divided into three catego-
ries: class I, class II, and class III. HLA-DR belongs to class II
molecules. The function of class II molecules is to serve anti-
genic peptide fragments to CD4 T-lymphocytes during the
beginning of immune responses [29]. Monocytes and macro-
phages express class II HLA-DR. This HLA-DR expression
on monocytes is one of the keys of immune system responses
because of the crucial role that HLA-DR plays in presenting
antigen to T lymphocytes [30].
The degree of suppression of (HLA-DR) expression signi-
ﬁes the degree of alteration of immune status in patients after
stressful insult [31], and may express potential risk of infection
[32] severe immuno-suppression [29], or immuno-incompe-
tence [33]. Also, the stress of anesthesia and surgery might lead
to suppression of monocytes with resultant decrease in mono-
cytic HLA-DR expression [29].
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pression of HLA-DR expression during intravenous anesthesia
with propofol, to balanced anesthesia with isoﬂurane or sevo-
ﬂurane. Their results showed no signiﬁcant alterations all
through the study time except at the third day postoperatively
when a decrease in the HLA-DR expression occurred. They
thought that the depression of HLA-DR expression was a sign
of immune-suppression caused by infectious complications
rather than anesthesia. On other hand, in another study done
by Tuna and coworkers [2], an increase in monocytic HLA-
DR expression occurred in the third postoperative day which
might be attributed to the improvement of the immune func-
tion. In the present study, control values for monocytic
HLA-DR expression were the patients’ own preoperative val-
ues. Suppression of HLA-DR expression was not detected in
both groups all through the study times indicating that neither
propofol nor sevoﬂurane affects HLA-DR expression on
monocytes.
5. Conclusion
VIMA with sevoﬂurane is less immunosuppressive than TIVA
with propofol in patients undergoing minor surgery. Further
studies will be needed to ensure that these results could help
anesthetists to select safer anesthetic circumstances especially
for immuno-compromised patients performing different types
of surgeries.
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